Latest Revenue Guidance News

Althea Group Holdings has sharply downgraded its FY25 financial guidance, citing significant challenges in its medicinal cannabis division and the strategic withdrawal from a vape product initiative. Despite the setback, the company highlights ongoing growth in its recreational cannabis operations and a strategic refocus on capital efficiency.

Hansen Technologies has secured a pivotal five-year, A$50 million contract with Virgin Media Limited (VMO2), licensing its cloud-native software suite to enhance VMO2’s operational platforms and customer engagement.

Nova Eye Medical has completed a $6.6 million placement to fund growth initiatives, supported by strong global sales growth and a major shareholder commitment. The capital raise aims to bolster sales teams and product development as the company targets profitability in its glaucoma division.

Nova Eye Medical reports a robust 39% increase in global sales driven by strong U.S. market demand and secures $6.6 million in fresh capital to fuel expansion and product development.

Fluence Corporation Limited delivered a standout Q4 2024 with $21.2 million revenue and $1 million EBITDA, driven by a strategic shift to higher-margin Smart Product Solutions. The company’s robust $88 million backlog and $50 million in new orders set the stage for ambitious growth in 2025.

Fluence Corporation delivered a standout Q4 2024 with revenue more than doubling prior quarters, overcoming project delays and market headwinds to set the stage for robust growth in 2025.

EVZ Limited has issued earnings guidance for the first half of FY2025, forecasting revenue between $53 million and $55 million and EBITDA ranging from $2.4 million to $2.6 million based on preliminary figures.

DXN Limited reported a robust 58.1% revenue increase to $4.8 million in Q2 FY25, underpinned by strategic capital raising and new product innovation targeting AI infrastructure. The company is advancing key mining and telecom projects while streamlining operations to support its ambitious $16 million revenue guidance for FY25.

Aroa Biosurgery has reported its first quarter of positive operating cash flow since listing on the ASX in 2020, alongside robust revenue growth projections and new regulatory approvals across key international markets.

PlaySide Studios reports a 21% revenue decline in 1HFY25 and revises full-year guidance downward, citing slower Work for Hire contracts and underperforming original IP sales. Despite short-term challenges, the company remains bullish on upcoming game launches.

Burgundy Diamond Mines met most operational and revenue targets in 2024 but missed EBITDA guidance by 6%, while preparing the Point Lake open pit for ore production in early 2025.

Pureprofile Limited has upgraded its FY25 financial guidance following a robust first half, highlighted by a 22% revenue increase and a 30% surge in Q2, driven by strong international expansion and automation adoption.